229 related articles for article (PubMed ID: 38396785)
21. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
[TBL] [Abstract][Full Text] [Related]
22. In vitro anticancer activity of Betulinic acid and derivatives thereof on equine melanoma cell lines from grey horses and in vivo safety assessment of the compound NVX-207 in two horses.
Liebscher G; Vanchangiri K; Mueller T; Feige K; Cavalleri JM; Paschke R
Chem Biol Interact; 2016 Feb; 246():20-9. PubMed ID: 26772157
[TBL] [Abstract][Full Text] [Related]
23. Betulinic Acid: Recent Advances in Chemical Modifications, Effective Delivery, and Molecular Mechanisms of a Promising Anticancer Therapy.
Ali-Seyed M; Jantan I; Vijayaraghavan K; Bukhari SN
Chem Biol Drug Des; 2016 Apr; 87(4):517-36. PubMed ID: 26535952
[TBL] [Abstract][Full Text] [Related]
24. Betulinic acid as a potent and complex antitumor phytochemical: a minireview.
Gheorgheosu D; Duicu O; Dehelean C; Soica C; Muntean D
Anticancer Agents Med Chem; 2014; 14(7):936-45. PubMed ID: 24568161
[TBL] [Abstract][Full Text] [Related]
25. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives.
Aswathy M; Vijayan A; Daimary UD; Girisa S; Radhakrishnan KV; Kunnumakkara AB
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23206. PubMed ID: 36124371
[TBL] [Abstract][Full Text] [Related]
26. Targeting mitochondrial apoptosis by betulinic acid in human cancers.
Fulda S; Kroemer G
Drug Discov Today; 2009 Sep; 14(17-18):885-90. PubMed ID: 19520182
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.
Santos RC; Salvador JA; Marín S; Cascante M; Moreira JN; Dinis TC
Bioorg Med Chem; 2010 Jun; 18(12):4385-96. PubMed ID: 20494586
[TBL] [Abstract][Full Text] [Related]
28. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and cytotoxicity of betulin and betulinic acid derived 30-oxo-amides.
Kozubek M; Hoenke S; Schmidt T; Deigner HP; Al-Harrasi A; Csuk R
Steroids; 2022 Jun; 182():109014. PubMed ID: 35314417
[TBL] [Abstract][Full Text] [Related]
30. Betulinic acid derivatives as anticancer agents: structure activity relationship.
Mukherjee R; Kumar V; Srivastava SK; Agarwal SK; Burman AC
Anticancer Agents Med Chem; 2006 May; 6(3):271-9. PubMed ID: 16712455
[TBL] [Abstract][Full Text] [Related]
31. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Characterization of Liposomes Modified with Biosurfactant MEL-A Loading Betulinic Acid and Its Anticancer Effect in HepG2 Cell.
Shu Q; Wu J; Chen Q
Molecules; 2019 Oct; 24(21):. PubMed ID: 31683639
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of phthalates of betulinic acid and betulin with cytotoxic activity.
Kvasnica M; Sarek J; Klinotova E; Dzubak P; Hajduch M
Bioorg Med Chem; 2005 May; 13(10):3447-54. PubMed ID: 15848757
[TBL] [Abstract][Full Text] [Related]
35. Design, semisynthesis and cytotoxic activity of novel ester derivatives of betulinic acid-1,2,4 oxadiazoles.
Challa K; Bhargavi MV; Krupadanam GL
J Asian Nat Prod Res; 2016 Dec; 18(12):1158-1168. PubMed ID: 27314626
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic applications of betulinic acid nanoformulations.
Saneja A; Arora D; Kumar R; Dubey RD; Panda AK; Gupta PN
Ann N Y Acad Sci; 2018 Jun; 1421(1):5-18. PubMed ID: 29377164
[TBL] [Abstract][Full Text] [Related]
37. Pentacyclic triterpenes of the lupane, oleanane and ursane group as tools in cancer therapy.
Laszczyk MN
Planta Med; 2009 Dec; 75(15):1549-60. PubMed ID: 19742422
[TBL] [Abstract][Full Text] [Related]
38. Betulinic acid and its derivatives: a review on their biological properties.
Yogeeswari P; Sriram D
Curr Med Chem; 2005; 12(6):657-66. PubMed ID: 15790304
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells.
Kutkowska J; Strzadala L; Rapak A
Chem Biol Interact; 2021 Jan; 333():109320. PubMed ID: 33181113
[TBL] [Abstract][Full Text] [Related]
40. [Advances in the study of structural modifications and biological activities of betulinic acids].
Lan P; Zhang DM; Chen WM; Ye WC
Yao Xue Xue Bao; 2010 Nov; 45(11):1339-45. PubMed ID: 21361032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
